Table 3.
Comparison of Characteristics of Eyes With Single-Time PPH to Eyes With Multiple-Times PPH
| Regression 1* | Regression 2† | |||||||
|---|---|---|---|---|---|---|---|---|
| Single-Time (67 Eyes) | Multiple-Times (30 Eyes) | B | OR (95%CI) | P | B | OR (95%CI) | P | |
| Sex | ||||||||
| Female | 44 (65.7%) | 23 (76.7%) | Ref. | Ref. | — | Ref. | — | |
| Male | 23 (34.3%) | 7 (23.3%) | −0.568 | 0.567 (0.135, 2.066) | 0.408 | −0.506 | 0.603 (0.143, 2.209) | 0.462 |
| Age (y), mean (SD) | 66.5 (12.7) | 67.4 (9.9) | 0.054 | 1.055 (0.990, 1.133) | 0.112 | 0.065 | 1.067 (0.999, 1.150) | 0.066 |
| Axial length (mm), mean (SD) | 30.55 (2.26) | 31.41 (1.83) | 0.554 | 1.741 (1.172, 2.802) | 0.012* | 0.622 | 1.863 (1.223, 3.112) | 0.009† |
| IOP (mm Hg), mean (SD) | 14.91 (3.56) | 15.32 (2.86) | — | — | — | — | ||
| Refractive error (D), mean (SD) | −14.85 (4.81) | −15.56 (7.57) | — | — | — | — | ||
| Median BCVA [25%; 75%] | 0.70 [0.25; 0.90] | 0.90 [0.12; 1.00] | 0.308 | 1.360 (0.361, 4.940) | 0.635 | 0.408 | 1.504 (0.350, 6.065) | 0.566 |
| Median absorption period (d), [25%; 75%] | 185.50 [126.00; 313.25] | 182.00 [126.00; 371.00] | — | — | — | — | ||
| Category of myopic maculopathy‡, eyes | 0.098 | 0.034 | ||||||
| Diffuse atrophy (C2) | 21 (31.3%) | 14 (46.7%) | Ref. | Ref. | — | Ref. | — | |
| Patchy atrophy (C3) | 33 (49.3%) | 9 (30.0%) | −1.669 | 0.188 (0.036, 0.796) | 0.031* | −2.158 | 0.116 (0.019, 0.526) | 0.009† |
| Macular atrophy (C4) | 13 (19.4%) | 7 (23.3%) | −2.040 | 0.130 (0.011, 1.125) | 0.080 | −3.279 | 0.038 (0.001, 0.500) | 0.027† |
| Possible ON damage | 11 (16.4%) | 12 (40.0%) | 1.366 | 3.920 (1.152, 14.506) | 0.032* | |||
| Possible glaucoma | 4 (6.0%) | 5 (16.7%) | 2.362 | 10.617 (1.578, 98.313) | 0.022† | |||
B, regression coefficient; Ref, reference; SD, standard deviation.
*
Multivariate binary regression analysis included sex, age, axial length, BCVA and category of myopic maculopathy, possible ON damage.
†
Multivariate binary regression analysis included sex, age, axial length, BCVA and category of myopic maculopathy, possible glaucoma.
‡
According to META-PM study classification.